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In the previous issue of Critical Care Th  omas Mueller 
and co-workers [1] presented their experience with a 
miniaturized veno-venous extracorporeal membrane 
oxy  gena  tion (ECMO) system in 60 consecutive patients 
with severe acute respiratory distress syndrome (ARDS). 
As a result, miniaturized ECMO was feasible, with a 
moderate rate of severe complications and 45% intensive 
care survival rate. Th   ese results have implications for the 
use of such systems outside the conventional indication 
of acute life-threatening hypoxemia.
Ever since its original description by Daniel Ashbaugh 
and co-workers in 1967 [2], hypoxemia in spite of high 
inspiratory oxygen fractions is the most apparent and 
acute life-threatening symptom of ARDS [3]. Under-
standably, ECMO was used solely to optimize blood gas 
status in the past. However, randomized clinical trials 
failed to demonstrate beneﬁ  cial eﬀ  ects of extracorporeal 
gas exchange on outcome at that time [4,5]. From a 
present-day perspective these negative results may be 
best explained by two major drawbacks of those studies: 
ﬁ   rst, the technical standard of those extracorporeal 
devices was limited; and second, extracorporeal gas 
exchange was performed as an additional therapy 
without rigorous adjustment of ventilator settings. 
Accordingly, two major strategies have been pursued in 
the past decade: ﬁ  rst, to reduce complications of extra-
corporeal gas exchange devices by technical progress; 
and second, to make use of this technique to provide lung 
protective mechanical ventilation. As a result, a recently 
published study was able to demonstrate at least some 
beneﬁ  cial eﬀ  ects on outcome due to a ﬁ  xed treatment 
algorithm including ECMO with up-to-date technology 
[6]. However, it should be noted that this trial - called 
CESAR (Conventional Versus ECMO for Severe Adult 
Respiratory Failure) - actually proves beneﬁ  cial eﬀ  ects 
due to treatment in a specialized ECMO-capable centre 
but not due to ECMO per se.
A further increase of eﬀ  ectiveness is suggested by the 
use of miniaturized ECMO circuits with small-sized but 
highly eﬀ  ective blood pumps and oxygenators, thereby 
reducing extracorporeal blood volume, foreign surfaces, 
contact activation of the coagulation system, inﬂ  am-
matory reactions, and blood trauma [7]. Moreover, these 
systems oﬀ  er practical advantages due to simple handling 
and increased system mobility. With such a miniaturized 
ECMO system Mueller and co-workers [1] carried out 
Abstract
Extracorporeal membrane oxygenation (ECMO) is 
widely accepted as a rescue therapy in patients with 
acute life-threatening hypoxemia in the course of 
severe acute respiratory distress syndrome (ARDS). 
However, possible side eff  ects and complications 
are considered to limit benefi  cial outcome eff  ects. 
Therefore, widening indications with the aim of 
reducing ventilator induced lung injury (VILI) is still 
controversial. Consequently, technological progress 
is an important strategy. Miniaturized ECMO systems 
are believed to simplify handling and reduce side 
eff  ects and complications. Mueller and co-workers 
evaluated such a small-sized device in 60 patients 
with severe ARDS. They accomplished both the 
treatment of severe hypoxemia and reduction of VILI, 
demonstrating feasibility, a moderate rate of severe 
complications, and a 45% intensive care survival rate. 
Although neither randomized nor controlled, this study 
should encourage others to implement such systems 
in clinical practice. From a strategic perspective, this is 
another small but useful step towards implementing 
extracorporeal gas exchange for the prevention of 
VILI. It is already common sense that the prevention of 
acute life-threatening hypoxemia usually outweighs 
the risks of this technique. The next step should be to 
prove that prevention of life-threatening VILI balances 
the risks too.
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© 2010 BioMed Central Ltdinterhospital transport in 10 of 60 patients without com-
pli  cations. All 60 patients were connected according to a 
predeﬁ  ned algorithm when conventional treatment strate-
gies failed to improve gas exchange. Not surprisingly, gas 
exchange improved signiﬁ  cantly due to ECMO treatment 
and death caused by acute hypoxemia could be prevented 
entirely. Additionally, tidal volumes were reduced below 
6 ml/kg ideal body weight, thereby accomplishing both 
aims of ECMO treatment, namely prevention of severe 
hypoxemia and reduction of ventilator induced lung 
injury (VILI). In summary, an up-to-date strategy of 
ECMO treatment was combined with up-to-date ECMO 
technology.
Th  erefore, it is astonishing, at ﬁ   rst glance, that the 
survival rate was substantially low compared to other 
trials [6,8]. However, with regard to severity of illness, 
organ failure, and age, these results appear acceptable. At 
least, this aspect can not be further evaluated without 
randomization and controls.
More interestingly, the authors stated that no life-
threatening complications and side eﬀ  ects occurred during 
the study period. On the other hand, several thrombotic 
and bleeding complications were reported. Moreover, 
ECMO implantation was accompanied with resuscitation 
in two patients and accidental dislocation of a backﬂ  ow 
cannula caused life-threatening hypoxia in another 
patient. Th  us, although all these patients could be 
stabilized immediately, it has to be realized that ECMO 
therapy still is not safe and easy at all and further studies 
and developments are still needed to further optimize 
ECMO technology.
However, the new technology presented by Mueller 
and co-workers is one step towards this. According to 
their experience it seems justiﬁ  ed to implement the use 
of miniaturized ECMO systems in clinical practice. In 
particular, this technique oﬀ   ers practical advantages 
during transport of ARDS patients. Given the possible 
advantages of treatment in specialized centers, as has 
been demonstrated in the CESAR trial, this option should 
be considered to enable transfer of patients with severe 
ARDS from peripheral hospitals.
Strictly speaking, scientiﬁ   c evidence for ECMO in 
ARDS patients with acute life-threatening hypoxemia is 
still lacking. However, due to ethical considerations, 
randomized controlled trials are diﬃ     cult to plan and 
perform. Th  erefore, the role of ECMO in this clinical 
situation will probably never be proved and ECMO is and 
will be accepted as a rescue therapy.
Scientiﬁ  c evidence for extracorporeal gas exchange in 
ARDS patients with life-threatening VILI is also lacking, 
and scarcely anybody would have ethical concerns about 
withholding extracorporeal gas exchange therapy from 
these patients     today. Th  erefore, randomized controlled 
trials are indicated to prove this concept with the lowest 
possible risk of side eﬀ  ects and complications. In this 
regard, the study by Mueller and co-workers is a small 
but useful step forward.
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